EvolutionaryScale’s Post

Join me on October 16 for the first-ever *AI Day* at Endpoints News. I'm so excited for this event to come to life and for you to join. The virtual event is free and registration is now open — sign up at the link below. I'll talk with some of the most important scientific and industry leaders that are determining just how far AI can reshape the drug R&D industry. We'll discuss different approaches across big pharma and startups, as well as what lies beyond the AlphaFold breakthrough for protein language models. The day will start with a fireside chat with none other than David Baker, director of the Institute for Protein Design, University of Washington. Baker's lab has continuously put out cutting-edge work in predicting and designing proteins with AI. And, oh, he also recently cofounded Xaira Therapeutics, which launched this year with a mere $1 billion in committed funding. Other speakers announced: Amgen CTO David Reese, EvolutionaryScale cofounder & ex-Meta scientist Alex Rives, and Inceptive CEO & transformer pioneer Jakob Uszkoreit. Sign up now: